- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股处于空头行情中，可能有短期反弹。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有52家主力机构披露2025-06-30报告期持股数据，持仓量总计2.68亿股，占流通A股38.66%
- 波段诊断：
-
技术面诊股
诊断结果：6.9技术面打败了93%的股票
技术面评分前10的股票
近期的平均成本为8.52元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为8.52元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.52","date":1774165978,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，跑赢行业平均水平。
[{"date":"2026.03.23","stock":"-5.30","trade":"-5.85","ind":"-3.76"},{"date":"2026.03.20","stock":"-0.67","trade":"-1.99","ind":"-0.25"},{"date":"2026.03.19","stock":"-3.04","trade":"-1.92","ind":"-2.02"},{"date":"2026.03.18","stock":"1.43","trade":"0.39","ind":"1.05"},{"date":"2026.03.17","stock":"-0.22","trade":"-0.68","ind":"-1.87"},{"date":"2026.03.16","stock":"0.33","trade":"0.40","ind":"0.19"},{"date":"2026.03.13","stock":"0.33","trade":"-0.37","ind":"-0.65"},{"date":"2026.03.12","stock":"-0.55","trade":"-0.63","ind":"-0.63"},{"date":"2026.03.11","stock":"1.45","trade":"-0.35","ind":"0.78"},{"date":"2026.03.10","stock":"2.87","trade":"1.42","ind":"2.04"},{"date":"2026.03.09","stock":"0.12","trade":"-0.27","ind":"-0.74"},{"date":"2026.03.06","stock":"2.24","trade":"1.93","ind":"0.59"},{"date":"2026.03.05","stock":"0.83","trade":"0.54","ind":"1.23"},{"date":"2026.03.04","stock":"-1.98","trade":"-1.09","ind":"-0.75"},{"date":"2026.03.03","stock":"-2.60","trade":"-1.58","ind":"-3.07"},{"date":"2026.03.02","stock":"-2.00","trade":"-2.12","ind":"-0.20"},{"date":"2026.02.27","stock":"0.33","trade":"0.36","ind":"-0.06"},{"date":"2026.02.26","stock":"-0.22","trade":"-0.47","ind":"0.19"},{"date":"2026.02.25","stock":"0.22","trade":"0.68","ind":"1.29"},{"date":"2026.02.24","stock":"-0.11","trade":"1.19","ind":"1.36"},{"date":"2026.02.13","stock":"0.00","trade":"-0.37","ind":"-1.28"}]
九芝堂,深证成指,中药指数
压力支撑
该股压力位为8.47元，支撑位为8.21元。
[{"text":"\u538b\u529b\u4f4d","value":"8.47","date":1774195200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.21","date":1774195200,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.6资金面打败了67%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：03月23日 20:30
| 机构今日流向(万元) | -2959.62 | 机构5日流向(万元) | -5401.42 |
| 机构10日流向(万元) | -6519.27 | 机构20日流向(万元) | -13506.32 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加7341.75万股，其中基金数没有增加，主力净增仓50家，有一定的中长期投资价值。
截止2025-06-30，共52家主力机构（基金49家，一般法人2家，社保基金1家），持仓量总计26835.81万股，占流通A股38.66%
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：50家 ，持有1991.75万股
从主力名单中消失：0家 ，原持有万股
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：50家 ，持有1991.75万股
从主力名单中消失：0家 ，原持有万股
消息面诊股
诊断结果：5.5消息面打败了25%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 九芝堂：非独立董事王永辉因个人原因辞职
2026-03-18 - 九芝堂：公司研发中心YB209项目完成免疫原性研究
2026-03-17 - 神经系统中成药市场冲刺140亿！24个独家品种上榜
2026-03-16 - 行业周报|中药指数跌-0.21%, 跑赢上证指数0
2026-03-13 - 2026年中国阿胶食品行业市场政策、产业链图谱、市
2026-03-10 - 两会聚焦中药产业升级，中药ETF银华涨1.07%
2026-03-06 - 九芝堂(3月5日)出现1笔大宗交易
2026-03-05 - 30个中成药爆火！11亿药王称霸，太极飙涨121%
2026-03-03 - 九芝堂：九芝堂美科的人骨髓间充质干细胞注射液治疗孤
2026-02-09 - 九芝堂：各子公司经营情况公司将在对外披露的年度报告
2026-02-09
消息列表
| 一般消息 | 高管变动 | 因个人原因 | 2026-03-18 |
| 一般消息 | 高管变动 | 因工作调整 | 2026-01-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-28 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-11-07 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-10 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-21 |
| 一般消息 | 高管变动 | 因工作变动原因 | 2025-07-17 |
| 一般消息 | 高管变动 | 因工作变动原因 | 2025-06-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-17 |
| 利好 | 上市变动 | 公司摘帽 | 2025-05-07 |
| 利好 | 分红转增 | 10派3元(含税) | 2025-03-28 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-28 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.3行业面打败了82%的股票
中药行业最新资金流向
近10日来该行业走势总体向下，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，跑输大盘。
[{"date":"2026.03.23","price":"-3.76","value":"-5.85"},{"date":"2026.03.20","price":"-0.25","value":"-1.99"},{"date":"2026.03.19","price":"-2.02","value":"-1.92"},{"date":"2026.03.18","price":"1.05","value":"0.39"},{"date":"2026.03.17","price":"-1.87","value":"-0.68"},{"date":"2026.03.16","price":"0.19","value":"0.40"},{"date":"2026.03.13","price":"-0.65","value":"-0.37"},{"date":"2026.03.12","price":"-0.63","value":"-0.63"},{"date":"2026.03.11","price":"0.78","value":"-0.35"},{"date":"2026.03.10","price":"2.04","value":"1.42"},{"date":"2026.03.09","price":"-0.74","value":"-0.27"},{"date":"2026.03.06","price":"0.59","value":"1.93"},{"date":"2026.03.05","price":"1.23","value":"0.54"},{"date":"2026.03.04","price":"-0.75","value":"-1.09"},{"date":"2026.03.03","price":"-3.07","value":"-1.58"},{"date":"2026.03.02","price":"-0.20","value":"-2.12"},{"date":"2026.02.27","price":"-0.06","value":"0.36"},{"date":"2026.02.26","price":"0.19","value":"-0.47"},{"date":"2026.02.25","price":"1.29","value":"0.68"},{"date":"2026.02.24","price":"1.36","value":"1.19"},{"date":"2026.02.13","price":"-1.28","value":"-0.37"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | ST百灵 | 4.59% | -10.76% | 4.5分 |
| 2 | 华润江中 | 3.21% | 2.26% | 6.4分 |
| 3 | 康惠股份 | 1.83% | -14.25% | 4.7分 |
| 4 | 羚锐制药 | 1.30% | 0.00% | 6.2分 |
| 5 | 万邦德 | 0.78% | 1.98% | 6.0分 |
| 6 | 华润三九 | 0.14% | -1.88% | 6.3分 |
| 8 | 健民集团 | -0.78% | 2.88% | 6.0分 |
| 10 | 云南白药 | -2.76% | -3.26% | 6.2分 |
| 12 | 济川药业 | -5.19% | -3.74% | 5.3分 |
| 14 | 天目药业 | -6.46% | -10.16% | 5.8分 |
| 16 | 九芝堂 | -6.67% | -7.70% | 5.4分 |
| 18 | 康缘药业 | -7.15% | -8.17% | 5.0分 |
| 20 | 桂林三金 | -7.61% | -5.05% | 6.1分 |
| 22 | 亚宝药业 | -7.85% | -8.82% | 5.4分 |
| 24 | 白云山 | -7.96% | -9.59% | 5.2分 |
| 26 | 康恩贝 | -8.35% | -8.56% | 4.5分 |
| 28 | 仁和药业 | -8.56% | -9.95% | 4.5分 |
| 30 | 中恒集团 | -8.70% | -12.50% | 4.5分 |
| 32 | ST葫芦娃 | -8.79% | -10.40% | 4.5分 |
| 34 | 古汉医药 | -9.11% | -6.93% | 5.5分 |
| 36 | 金花股份 | -9.66% | -10.39% | 5.3分 |
| 38 | 千金药业 | -9.81% | -9.65% | 5.7分 |
| 40 | 精华制药 | -10.20% | -11.83% | 5.0分 |
| 42 | 华神科技 | -10.50% | -15.17% | 4.9分 |
| 44 | 上海凯宝 | -10.51% | -11.64% | 4.6分 |
| 46 | 众生药业 | -11.77% | -8.58% | 5.0分 |
| 48 | 华森制药 | -12.08% | -8.98% | 5.0分 |
| 50 | 寿仙谷 | -12.48% | -9.27% | 4.4分 |
| 52 | 益盛药业 | -12.98% | -14.12% | 4.8分 |
| 54 | 新光药业 | -13.88% | -13.56% | 4.8分 |
| 56 | 陇神戎发 | -14.70% | -12.35% | 5.3分 |
| 58 | 沃华医药 | -15.08% | -11.95% | 5.5分 |
| 60 | 恩威医药 | -15.95% | -13.40% | 5.4分 |
| 62 | - | -16.30% | -13.20% | 分 |
| 64 | 特一药业 | -17.09% | -9.02% | 5.8分 |
| 66 | 汉森制药 | -18.08% | -13.16% | 4.8分 |
| 68 | 粤万年青 | -21.64% | -11.89% | 5.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 38/108 ， 26/108。
[{"date":"2025-09-30","value":"4.09","vol":"4.74"},{"date":"2025-06-30","value":"3.89","vol":"3.98"},{"date":"2025-03-31","value":"3.06","vol":"2.21"},{"date":"2024-12-31","value":"5.61","vol":"4.80"},{"date":"2024-09-30","value":"6.22","vol":"2.91"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.09 | 3.89 | 3.06 | 5.61 | 6.22 |
| 行业(%) | 4.74 | 3.98 | 2.21 | 4.80 | 2.91 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"59.80","vol":"52.48"},{"date":"2025-06-30","value":"59.35","vol":"53.04"},{"date":"2025-03-31","value":"60.04","vol":"53.56"},{"date":"2024-12-31","value":"59.12","vol":"52.79"},{"date":"2024-09-30","value":"59.03","vol":"53.11"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
59.80 | 59.35 | 60.04 | 59.12 | 59.03 |
| 行业(%) | 52.48 | 53.04 | 53.56 | 52.79 | 53.11 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 54/108 ， 52/108。
[{"date":"2025-09-30","value":"-21.13","vol":"-7.63"},{"date":"2025-06-30","value":"-24.71","vol":"-7.68"},{"date":"2025-03-31","value":"-25.36","vol":"-7.53"},{"date":"2024-12-31","value":"-19.91","vol":"-7.39"},{"date":"2024-09-30","value":"-12.94","vol":"-5.11"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-21.13 | -24.71 | -25.36 | -19.91 | -12.94 |
| 行业(%) | -7.63 | -7.68 | -7.53 | -7.39 | -5.11 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-36.94","vol":"-2.70"},{"date":"2025-06-30","value":"-29.71","vol":"2.90"},{"date":"2025-03-31","value":"-19.40","vol":"-37.21"},{"date":"2024-12-31","value":"-27.31","vol":"-146.29"},{"date":"2024-09-30","value":"-16.77","vol":"61.78"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-36.94 | -29.71 | -19.40 | -27.31 | -16.77 |
| 行业(%) | -2.70 | 2.90 | -37.21 | -146.29 | 61.78 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 41/108 ， 62/108。
[{"date":"2025-09-30","value":"0.32","vol":"0.35"},{"date":"2025-06-30","value":"0.25","vol":"0.24"},{"date":"2025-03-31","value":"0.15","vol":"0.12"},{"date":"2024-12-31","value":"0.45","vol":"0.50"},{"date":"2024-09-30","value":"0.39","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.32 | 0.25 | 0.15 | 0.45 | 0.39 |
| 行业(次) | 0.35 | 0.24 | 0.12 | 0.50 | 0.37 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.68","vol":"1.72"},{"date":"2025-06-30","value":"0.54","vol":"1.18"},{"date":"2025-03-31","value":"0.33","vol":"0.60"},{"date":"2024-12-31","value":"0.96","vol":"2.41"},{"date":"2024-09-30","value":"0.89","vol":"1.81"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.68 | 0.54 | 0.33 | 0.96 | 0.89 |
| 行业(次) | 1.72 | 1.18 | 0.60 | 2.41 | 1.81 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"26.98","vol":"9.43"},{"date":"2025-06-30","value":"34.30","vol":"20.06"},{"date":"2025-03-31","value":"6.91","vol":"-0.30"},{"date":"2024-12-31","value":"88.25","vol":"15.76"},{"date":"2024-09-30","value":"41.55","vol":"5.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 26.98 | 34.30 | 6.91 | 88.25 | 41.55 |
| 行业 | 9.43 | 20.06 | -0.30 | 15.76 | 5.86 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.47","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.58","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.47 | - | 0.58 | - |
| 行业 | 0.00 | 1.02 | 0.00 | 1.45 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 26/108 ， 34/108。
[{"date":"2025-09-30","value":"2.66","vol":"3.05"},{"date":"2025-06-30","value":"2.57","vol":"2.90"},{"date":"2025-03-31","value":"2.55","vol":"2.99"},{"date":"2024-12-31","value":"2.51","vol":"2.88"},{"date":"2024-09-30","value":"2.03","vol":"3.25"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.66 | 2.57 | 2.55 | 2.51 | 2.03 |
| 行业 | 3.05 | 2.90 | 2.99 | 2.88 | 3.25 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.74","vol":"2.21"},{"date":"2025-06-30","value":"1.71","vol":"2.13"},{"date":"2025-03-31","value":"1.74","vol":"2.22"},{"date":"2024-12-31","value":"1.51","vol":"2.11"},{"date":"2024-09-30","value":"1.31","vol":"2.43"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.74 | 1.71 | 1.74 | 1.51 | 1.31 |
| 行业 | 2.21 | 2.13 | 2.22 | 2.11 | 2.43 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 40/108 ， 42/108。
[{"date":"2025-09-30","value":"22.77","vol":"33.12"},{"date":"2025-06-30","value":"23.45","vol":"33.87"},{"date":"2025-03-31","value":"24.47","vol":"33.29"},{"date":"2024-12-31","value":"24.24","vol":"34.05"},{"date":"2024-09-30","value":"28.23","vol":"32.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
22.77 | 23.45 | 24.47 | 24.24 | 28.23 |
| 行业(%) | 33.12 | 33.87 | 33.29 | 34.05 | 32.87 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.31","vol":"0.75"},{"date":"2025-06-30","value":"0.32","vol":"0.74"},{"date":"2025-03-31","value":"0.34","vol":"0.72"},{"date":"2024-12-31","value":"0.34","vol":"0.75"},{"date":"2024-09-30","value":"0.39","vol":"3.20"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.31 | 0.32 | 0.34 | 0.34 | 0.39 |
| 行业(%) | 0.75 | 0.74 | 0.72 | 0.75 | 3.20 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"2.71","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"3.58","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.97","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"2.16","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"2.02","blueLineValue":"0.24","type":"YC"}]